1002.50 -28.20 (-2.74%)

130.57% Gain from 52W Low

448.1K Volume

NSEJan 20, 2021 11:54 AM



Alembic Pharmaceuticals Ltd.    
19 Jan 2021, 01:18PM
1002.50
-2.74%
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Consolidated & Standalone Unaudited Financial Results For The Quarter And ...
BSE India
With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited Financial Results for the quarter and nine months period ended on 31st December, 2020. We enclose herewith the following: a) Consolidated Unaudited Financial Results for the quarter and nine months period ended on 31st December, 2020. b) Standalone Unaudited Financial Results for the quarter and nine months period ended on 31st December, 2020. c) Limited Review Report by Statutory Auditors on Consolidated as well as on Standalone Unaudited Financial Results. d) Press Release. e) Investor Presentation. The time of commencement of the Board Meeting was 11:30 a.m. and the time of conclusion was 1:00 p.m. We request you to kindly take the same on record.
default
Alembic Pharmaceuticals Ltd.    
19 Jan 2021, 01:13PM
1002.50
-2.74%
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Outcome Of Board Meeting
BSE India
With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited Financial Results for the quarter and nine months period ended on 31st December, 2020. We enclose herewith the following: a) Consolidated Unaudited Financial Results for the quarter and nine months period ended on 31st December, 2020. b) Standalone Unaudited Financial Results for the quarter and nine months period ended on 31st December, 2020. c) Limited Review Report by Statutory Auditors on Consolidated as well as on Standalone Unaudited Financial Results. d) Press Release. e) Investor Presentation. The time of commencement of the Board Meeting was 11:30 a.m. and the time of conclusion was 1:00 p.m. We request you to kindly take the same on record.
1002.50
-2.74%
1002.50
-2.74%
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Newspaper Publication
BSE India
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of Notice of Board Meeting published in English and vernacular language (Gujarati) newspaper on 8th January, 2021 in Economic Times English Edition, Indian Express English Edition and Financial Express Gujarati Edition. We request you to kindly take the same on record.
1002.50
-2.74%
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Shareholding for the Period Ended December 31, 2020
BSE India
Alembic Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here
1002.50
-2.74%
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Board Meeting Intimation for Board Meeting To Consider Unaudited Financial ...
BSE India
ALEMBIC PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/01/2021 ,inter alia, to consider and approve With reference to the captioned matter, the exchange is hereby informed that a Meeting of Board of Directors of the Company will be held on Tuesday, 19th January, 2021, inter-alia to consider and approve Unaudited Financial Results of the Company for the quarter and nine months period ended 31st December, 2020. Pursuant to the Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons and their Immediate Relatives, the trading window for dealing in securities of the Company which was closed from 1st January, 2021, will re-open 48 hours after the declaration of the financial results. We request you to kindly take the same on record.
1002.50
-2.74%
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Statement Of Investor Complaints For The Quarter Ended December 2020
BSE India
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0550 Name of the Signatory :- Charandeep Singh SalujaDesignation :- Company Secretary and Compliance Officer
1002.50
-2.74%
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
BSE India
With reference to the captioned matter, please find enclosed herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st December, 2020, received from M/s. Link Intime India Private Limited, Registrar and Share Transfer Agent of our Company. We request you to kindly take the same on record.
default
1002.50
-2.74%
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Closure of Trading Window
BSE India
With reference to the captioned matter, this is to inform the exchange that in terms of the Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons and their Immediate Relatives framed pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in securities of the Company will remain closed from 1st January, 2021 till 48 hours after the declaration of the unaudited financial results for the quarter and nine months period ended 31st December, 2020. The date of the Board Meeting for considering the unaudited financial results for the quarter and nine months period ended 31st December, 2020 will be intimated in due course. We request you to kindly take the same on record.
1002.50
-2.74%
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Newspaper Publication
BSE India
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of advertisement related to notice of loss of share certificate(s) published by the Company on behalf of the registered shareholder(s) in English language newspaper - Business Standard on 25th December, 2020. We request you to kindly take the same on record.
  • Stock Price (993.2) crossed above 30 Day SMA (973.1) on 23 November, 2020
  • Stock Price (993.2) crossed above 100 Day SMA (971.52) on 23 November, 2020
  • Stock Price (938.3) crossed below 50 Day SMA (954.99) on 10 November, 2020
  • KRChoksey upgraded Alembic Pharmaceuticals Ltd. to Buy with a price target of 1286.0 on 28 Oct, 2020.
  • Month Change by 21.88% (Crossed threshold 20%) on 06 August, 2020
More triggered alerts
Ex-Date Dividend Amount Dividend Type Record Date
March 16, 20207.00INTERIMMarch 17, 2020
March 16, 20203.00SPECIALMarch 17, 2020
July 18, 20195.50FINAL-
July 18, 20184.00FINAL-
July 11, 20174.00FINAL-
All dividends by APLLTD